ReShape Lifesciences Inc. (NASDAQ:RSLS) Consensus Call At 1
As regular trading ended, ReShape Lifesciences Inc. (RSLS) stock brought in a -$0.75 drop to $2.49. The day started at a price of $2.8 but then traded as high as $2.85 before giving part of the gains back. As for this week, analysts appear content to stick with their bright outlook with the consensus call at 1. ReShape Lifesciences Inc. is given 1 buy-equivalent recommendations, 0 sells and 0 holds. The company shares sank -96.86% from their peak of $79.20 and now has a $6.15 million market value of equity.
ReShape Lifesciences Inc. Could Grow 1185.14% More
RSLS’s mean recommendation on Reuter’s scale presents no change from 1 thirty days ago to 1 now, which indicates a buy consensus from the analyst community. They see ReShape Lifesciences Inc. (RSLS) price hitting a mean target of $32 a share, meaning the stock still has potential that could lift the price another 1185.14% Also, the recent close suggests the stock is underpriced by 1185.14% compared to the most bullish target.
ReShape Lifesciences Inc. (RSLS) Returns -88.78% This Year
The company had seen its current volume reaching at 1.06 million shares in the last trade. That compares with the recent volume average of 0.08 million. At the close of regular trading, its last week’s stock price volatility was 14.04% which for the month reaches 16.51%. ReShape Lifesciences Inc. dipped to as low as $2.48 throughout the day and has returned -88.78% in this year. At one point in the past year, the shares traded as low as $3.01 but has recovered -17.28% since then.
https://postanalyst.com/2018/06/21/could-today-be-a-major-turning-point-bank-of-america-corporation-bac-reshape-lifesciences-inc-rsls/
